Streetbeat News

Products Services

ACXP

Acurx Pharmaceuticals has reported a successful FDA end-of-Phase 2 meeting and is ready to advance ibezapolstat into Phase 3 clinical trials for treating C. difficile Infection. The company has also received SME designation from the EMA, which provides fee incentives and support for EU Marketing Authorization.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 1:02 pm

AMC

GME

A trader known as 'Bonk Guy' revealed a seven-figure profit in 48 hours trading AMC and GameStop meme coins on Solana. The AMC/SOL and GME/SOL pairs saw massive gains, significantly outperforming larger meme coins like Dogecoin and Shiba Inu. Bonk Guy suggests that if the narrative around AMC and GME remains strong, their stocks could continue to rise, bringing more attention to decentralized derivatives on Solana.

Portfolio Pulse from Khyathi Dalal

May 15, 2024 | 1:01 pm

HYMTF

TM

TSLA

VWAGY

WKSP

Hyundai Motor Group surpassed Volkswagen Group in operating profit for Q1 2024, with Toyota Group maintaining its lead. Hyundai's diverse portfolio and investments in technical capabilities, including a partnership with Worksport Ltd, contributed to its success. Volkswagen faces challenges in the EV market, particularly in China, and has partnered with Xpeng to improve its position.

Portfolio Pulse from Upwallstreet

May 15, 2024 | 12:55 pm

NFLX

Netflix is nearing a deal to acquire rights for NFL games, marking a significant push into the sports streaming market.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 12:54 pm

AMZN

VCR

XLY

Amazon's AWS plans to invest €7.8 billion in the AWS European Sovereign Cloud in Germany by 2040, starting with a new AWS Region in Brandenburg by 2025. This investment aims to drive digital transformation, enhance the AWS Partner Network, and support renewable energy projects, contributing €17.2 billion to Germany's GDP and sustaining 2,800 jobs annually. AWS will also create new permanent positions and ensure compliance with EU regulations.

Portfolio Pulse from Shivani Kumaresan

May 15, 2024 | 12:53 pm

VNDA

Vanda Pharmaceuticals announced positive results from its second Phase III study of tradipitant, confirming its efficacy in preventing motion sickness-related vomiting.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 12:46 pm

IMNN

Imunon announced that its abstract on a Phase 2 study with IMNN-001 in combination with Bevacizumab has been accepted for presentation at the ASCO Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 12:44 pm

NIO

Nio Inc. (NYSE:NIO) has announced that its new sub-brand Onvo, which will focus on mass-market EVs, will be led by former Disney executive Ai Tiecheng. Onvo's first EV, the L60 SUV, is designed to compete with Tesla's Model Y and is expected to launch globally by the end of the year.

Portfolio Pulse from Anan Ashraf

May 15, 2024 | 12:43 pm

SHOT

Safety Shot, Inc. (NASDAQ:SHOT) is set to introduce its rapid alcohol reducer product in 50 targeted 7-Eleven stores in Los Angeles in June, with plans to expand to over 300 locations across Southern California and eventually launch nationally.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 12:41 pm

MBRX

Moleculin Biotech has commenced a Phase 2 clinical trial of its STAT3 inhibitor, WP1066, for glioblastoma. The trial, funded by the NIH, is being conducted at Northwestern University and combines WP1066 with radiation, showing promising results in animal models.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 12:40 pm